Nazish Masoodi, MD | |
701 W Cocoa Beach Cswy, Cch/hospitalist Program, Cocoa Beach, FL 32931-3585 | |
(321) 868-5871 | |
(321) 868-5852 |
Full Name | Nazish Masoodi |
---|---|
Gender | Female |
Speciality | Hospitalist |
Location | 701 W Cocoa Beach Cswy, Cocoa Beach, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356384127 | NPI | - | NPPES |
ME95536 | Other | FL | MD LICENSE |
275599800 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | ME95536 (Florida) | Secondary |
208M00000X | Hospitalist | ME95536 (Florida) | Primary |
Entity Name | Indian River Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710933031 PECOS PAC ID: 9234130329 Enrollment ID: O20070116000060 |
News Archive
With implications for the transmission of diseases like COVID-19, researchers have found that ordinary conversation creates a conical 'jet-like' airflow that quickly carries a spray of tiny droplets from a speaker's mouth across meters of interior space.
Obama signed an executive order on Friday, directing the Veterans Administration to hire 1,600 new mental health professionals and to expand the capacity of its crisis line so those who are in crisis can see a counselor within 24 hours. ... The White House says money for the additional mental health care will come from existing resources, though the president sought a 10-percent increase in overall VA funding next year.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Nazish Masoodi, MD Po Box 561600, Rockledge, FL 32956-1600 Ph: (321) 434-4600 | Nazish Masoodi, MD 701 W Cocoa Beach Cswy, Cch/hospitalist Program, Cocoa Beach, FL 32931-3585 Ph: (321) 868-5871 |
News Archive
With implications for the transmission of diseases like COVID-19, researchers have found that ordinary conversation creates a conical 'jet-like' airflow that quickly carries a spray of tiny droplets from a speaker's mouth across meters of interior space.
Obama signed an executive order on Friday, directing the Veterans Administration to hire 1,600 new mental health professionals and to expand the capacity of its crisis line so those who are in crisis can see a counselor within 24 hours. ... The White House says money for the additional mental health care will come from existing resources, though the president sought a 10-percent increase in overall VA funding next year.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
› Verified 9 days ago
Dr. Victor Manuel Vargas, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931 Phone: 321-868-5871 Fax: 321-868-5852 | |
Dr. Faizal Rahaman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cch/hospitalist Dept, Cocoa Beach, FL 32931 Phone: 321-868-5871 Fax: 321-868-5852 | |
Dr. Lan Tuyet Phan, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931 Phone: 321-868-5871 Fax: 321-868-5852 | |
Miguel A Medina, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931 Phone: 321-868-5871 Fax: 321-868-5852 | |
Dr. Pramesh Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931 Phone: 321-868-5871 Fax: 321-868-5852 | |
Jenakan Jeramian Dev, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931 Phone: 321-434-1771 | |
Dr. Lillian Gonzales Sepulveda, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 W Cocoa Beach Cswy, Cocoa Beach, FL 32931 Phone: 321-868-5871 Fax: 321-868-5852 |